| Literature DB >> 32042535 |
Glenn G Shi1, Douglas S Schultz1, Joseph Whalen1, Steven Clendenen2, Benjamin Wilke1.
Abstract
BACKGROUND: While total knee arthroplasty (TKA) is a reliable treatment for advanced knee arthritis, up to 19% of patients after TKA remain dissatisfied, especially with residual pain. A less known source of medial knee pain following TKA is infrapatellar saphenous neuroma. Ultrasound-guided local treatment with hydrodissection and corticosteroid injection is an effective short-term solution. Our primary aim was to evaluate the durability of local treatment by comparing numeric pain scores for medial knee pain after TKA at pretreatment, one month following treatment, and midterm follow-up. A secondary aim was to identify associations of patient characteristics with degree of change in numeric pain score.Entities:
Keywords: neuroma; revision total knee arthroplasty; total knee arthroplasty
Year: 2020 PMID: 32042535 PMCID: PMC6996533 DOI: 10.7759/cureus.6565
Source DB: PubMed Journal: Cureus ISSN: 2168-8184
Patient Characteristics and Outcomes
BMI, body mass index; TKA, total knee arthroplasty.
aInformation given as no. (%) unless otherwise indicated.
bInformation was unavailable regarding BMI (n=3), diabetes mellitus (n=1), revised TKA (n=1), history of psychiatric disorders (n=1), and history of tobacco use (n=1).
| Variablea | Summary (N=29) |
| Pretreatment and treatment characteristics | |
| Age at treatment, median (range), years | 65.9 (34.7 to 79.8) |
| Sex, male | 7 (24.1%) |
| BMI, median (range)b | 32.6 (20.2 to 41.3) |
| Diabetes mellitusb | 5 (17.9%) |
| Fibromyalgia | 10 (34.5%) |
| Revised TKA prior to treatmentb | 6 (21.4%) |
| Number of knee surgeries prior to treatment | |
| 1 | 9 (31.0%) |
| 2 | 8 (27.6%) |
| 3 | 2 (6.9%) |
| 4 | 3 (10.3%) |
| 5 | 2 (6.9%) |
| >5 | 5 (17.2%) |
| Pretreatment narcotic use | 6 (20.7%) |
| History of psychiatric disordersb | 5 (17.9%) |
| History of tobacco useb | 9 (32.1%) |
| Medial knee numeric pain score, median (range) | 9 (5 to 10) |
| Treated knee | |
| Left | 10 (34.5%) |
| Right | 19 (65.5%) |
| Medial knee numeric pain score outcomes, median (range) | |
| One-month follow-up | 5 (0 to 10) |
| Midterm follow-up (4.6 years) | 5 (0 to 10) |
| One-month follow-up minus pretreatment | −4 (−8 to 0) |
| Midterm follow-up minus pretreatment | −3 (−10 to 1) |
| Midterm follow-up minus onemonth follow-up | 0 (−8 to 7) |
Figure 1Boxplots Showing Medial Knee Numeric Pain Score Pretreatment, at One-month Follow-up, and at Midterm Follow-up at 4.6 Years
VAS, visual analog scale.
Associations of Continuous Patient Characteristics with Change in Numeric Pain Score from Pretreatment and One-month Follow-up to Midterm Follow-up at 4.6 years
BMI, body mass index.
aCalculated as the medial knee numeric pain score at midterm follow-up following treatment minus the medial knee numeric pain score at pretreatment.
bCalculated as the medial knee numeric pain score at midterm follow-up following treatment minus the medial knee numeric pain score at one month following treatment.
cP-values result from Spearman rank correlation.
| Change From Pretreatment to Midterm Follow-upa | Change From One-month to Midterm Follow-upb | |||
| Variable | Spearman r | P-Valuec | Spearman r | P-Valuec |
| Age at treatment | 0.40 | 0.03 | −0.02 | 0.91 |
| BMI | 0.00 | 0.99 | −0.11 | 0.59 |
| No. of knee surgeries prior to treatment | 0.04 | 0.83 | 0.16 | 0.41 |
| Pretreatment medial knee numeric pain score | −0.20 | 0.31 | −0.01 | 0.95 |
Associations of Categorical Patient Characteristics with Change in Numeric Pain Score from Pretreatment and One-month Follow-up to Midterm Follow-up at 4.6 Years
TKA, total knee arthroplasty.
aThis was calculated as the medial knee numeric pain score at midterm follow-up following treatment minus the medial knee numeric pain score at pretreatment.
bThis was calculated as the medial knee numeric pain score at midterm follow-up following treatment minus the medial knee numeric pain score at one month following treatment.
cP-values result from a Wilcoxon rank-sum test.
| Change From Pretreatment to Midterm Follow-upa | Change From One-month to Midterm Follow-upb | |||
| Variable | Median (Range) | P-Valuec | Median (Range) | P-Valuec |
| Sex | 0.50 | 0.03 | ||
| Male (n=7) | −2 (−10 to 0) | −1 (−8 to 1) | ||
| Female (n=22) | −3 (−10 to 1) | 0 (−5 to 7) | ||
| Treated knee | 0.35 | 0.78 | ||
| Right (n=19) | −2 (−10 to 1) | 0 (−8 to 6) | ||
| Left (n=10) | −4 (−8 to 0) | 0 (−2 to 7) | ||
| Diabetes mellitus | 0.48 | 0.56 | ||
| Yes (n=5) | −4 (−10 to 0) | 0 (−5 to 7) | ||
| No (n=23) | −2 (−10 to 1) | 0 (−8 to 6) | ||
| Fibromyalgia | 0.98 | 0.01 | ||
| Yes (n=10) | −3 (−8 to 1) | 2 (0 to 7) | ||
| No (n=19) | −3 (−10 to 0) | 0 (−8 to 5) | ||
| Revised TKA—chart review | 0.12 | 0.02 | ||
| Yes (n=6) | −1 (−8 to 1) | 2 (0 to 7) | ||
| No (n=22) | −3 (−10 to 0) | 0 (−8 to 5) | ||
| Pretreatment narcotic use | 0.72 | 0.66 | ||
| Yes (n=6) | −3 (−10 to 0) | 0 (−5 to 2) | ||
| No (n=23) | −3 (−10 to 1) | 0 (−8 to 7) | ||
| History of psychiatric disorders | 0.50 | 0.64 | ||
| Yes (n=5) | −5 (−8 to 0) | 0 (0 to 7) | ||
| No (n=23) | −2 (−10 to 1) | 0 (−8 to 6) | ||
| History of tobacco use | 0.75 | 0.24 | ||
| Yes (n=9) | −2 (−8 to 0) | 0 (−2 to 5) | ||
| No (n=19) | −3 (−10 to 1) | 0 (−8 to 7) | ||